Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Public Health Vaccination topic
No spam. Unsubscribe anytime.
HPV vaccine bill draws heated floor debate as Iowa House votes to require parental consent
Summary
Lawmakers debated Senate File 304 at length before passing it; physician-lawmakers and opponents exchanged data claims about vaccination rates, cancer risk and minors' capacity to consent, and lawmakers emphasized parental rights versus adolescent access to preventive care.
The Iowa House debated Senate File 304 on the floor and approved the bill that would require parental consent before physicians may administer the HPV and hepatitis B vaccines to minors.
Representative (Appanoose) opened the discussion by saying the bill would align requirements for parental consent for the HPV and hepatitis B vaccines. The measure drew extended questioning from members about vaccine indications and the appropriate age range.
Representative Bateman, who identified herself as a practicing physician, said that in states where adolescents may consent to their own vaccines HPV vaccination rates have been observed to be higher. "The data show that in states that have policies that allow adolescents to consent to their own vaccine, HPV vaccination rate is 10 percent higher," she said on the floor, and described clinical considerations about therapeutic relationships and care for minors who may be victims of abuse.
Opponents framed the bill as a protection of parental authority. Representative Shipley said the legislation "secures parental rights," arguing that parents should be trusted to make decisions about their children’s health. At one point, Representative Bateman pushed back against the characterization that opponents were denying vaccine benefits, and she emphasized the vaccines' role in cancer prevention.
The debate included technical questions about the vaccine product and eligible ages: Bateman confirmed the Gardasil product is indicated for children as young as 9 and said selection of timing depends on individual clinical judgment. Colleagues asked for citations on population-level claims; the exchange recorded several hypotheses and differing interpretations of data.
Representative (Appanoose) closed by noting differing interpretations of evidence and urging the House to move forward. The bill passed on a recorded vote (ayes 63; no 29; absent/not voting 8). The transcript records exchanges about cancer incidence, vaccine indications and child-protection considerations but does not include formal evidence citations on the floor.
The House journal shows the measure will be messaged to the Senate for further processing.
Ending: The bill was declared passed by constitutional majority and the House adjourned; implementation details, program guidance and any rulemaking would follow as the law moves through the remaining steps to final enactment.
